Eisai Co., Ltd. (TYO: 4523)
Japan
· Delayed Price · Currency is JPY 4,226.00
-14.00 (-0.33%)
Jan 20, 2025, 3:30 PM JST
Eisai Employees
Eisai had 11,067 employees as of March 31, 2024. The number of employees decreased by 9 or -0.08% compared to the previous year.
Employees
11,067
Change (1Y)
-9
Growth (1Y)
-0.08%
Revenue / Employee
68.06M JPY
Profits / Employee
3.70M JPY
Market Cap
1,191.26B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Chugai Pharmaceutical | 7,604 |
| Daiichi Sankyo Company | 18,726 |
| HOYA Corporation | 35,702 |
| Takeda Pharmaceutical Company | 49,281 |
| Otsuka Holdings | 34,388 |
| Astellas Pharma | 14,754 |
| Olympus | 28,838 |
| Shionogi & | 4,959 |
Eisai News
- 6 days ago - Biogen, Eisai say injectable Alzheimer’s therapy granted FDA review - Seeking Alpha
- 4 weeks ago - Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases - Business Wire
- 5 weeks ago - Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia - Benzinga
- 6 weeks ago - Biogen Inc (BIIB) and Eisai's Alzheimer's Drug LEQEMBI Approved in Mexico - GuruFocus
- 2 months ago - Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026 - Benzinga
- 2 months ago - Eisai wins orphan drug status for Lenvima for esophageal cancer - Seeking Alpha
- 2 months ago - Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease - PRNewsWire
- 2 months ago - Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug - MarketWatch